However, as they applied non-liver-specific CD8 T cell knock out models, an extrahepatic CD8 T cell inhibition resulting in a modified microbiome or their inhibition in fatty tissue could play the critical role in NASH suppression. Here, CD8A is linked to metabolic dysfunction-associated steatohepatitis.